PuraPharm Corporation Limited (HKG:1498)
Hong Kong
· Delayed Price · Currency is HKD 0.4800
-0.0100 (-2.04%)
May 16, 2025, 1:57 PM HKT
PuraPharm Corporation Cash Flow Statement
Financials in millions HKD. Fiscal year is January - December.
Millions HKD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Net Income | -35.44 | -106.08 | -120.21 | -121.88 | 31.71 | Upgrade
|
| Depreciation & Amortization | 52.49 | 45.57 | 45.83 | 47.26 | 45.48 | Upgrade
|
| Other Amortization | 2.1 | 5.33 | 4.2 | 3.13 | 2.14 | Upgrade
|
| Loss (Gain) From Sale of Assets | -1 | 1.29 | -0.04 | -0.18 | 2.11 | Upgrade
|
| Asset Writedown & Restructuring Costs | 2.77 | 32.71 | 41.3 | 116 | -20.11 | Upgrade
|
| Loss (Gain) From Sale of Investments | -1.44 | 0 | -0.17 | -0.3 | -0.06 | Upgrade
|
| Loss (Gain) on Equity Investments | 0.31 | 0.15 | - | - | - | Upgrade
|
| Stock-Based Compensation | 1.45 | 4.29 | 0.27 | 3.5 | 5.64 | Upgrade
|
| Provision & Write-off of Bad Debts | -1 | 2.73 | 10.55 | 17.03 | 10.83 | Upgrade
|
| Other Operating Activities | 30.41 | 31.61 | 25.63 | 34.16 | 21.9 | Upgrade
|
| Change in Accounts Receivable | 23.61 | 47.09 | 105.45 | -51.19 | 10.68 | Upgrade
|
| Change in Inventory | 50.37 | -6.44 | -17.23 | 4.68 | 11.34 | Upgrade
|
| Change in Accounts Payable | -10.81 | 10.47 | 9.61 | -22.56 | -29.62 | Upgrade
|
| Change in Unearned Revenue | 0.86 | -0.01 | -2.05 | -3.22 | 2.52 | Upgrade
|
| Change in Income Taxes | - | 5.84 | -4.17 | - | - | Upgrade
|
| Change in Other Net Operating Assets | -10.69 | 5.08 | -10.45 | -40.94 | 25.29 | Upgrade
|
| Operating Cash Flow | 103.99 | 79.61 | 88.51 | -14.52 | 119.85 | Upgrade
|
| Operating Cash Flow Growth | 30.62% | -10.05% | - | - | -8.65% | Upgrade
|
| Capital Expenditures | -14.81 | -19.18 | -20.83 | -3.09 | -76.05 | Upgrade
|
| Sale of Property, Plant & Equipment | 3.48 | - | 0.1 | 2.89 | 0.68 | Upgrade
|
| Sale (Purchase) of Intangibles | -1.58 | -2.48 | -1.89 | -3.47 | -6.8 | Upgrade
|
| Investment in Securities | - | -0.63 | -1.98 | - | - | Upgrade
|
| Other Investing Activities | 1.19 | 4.09 | -6.64 | 9.67 | -9.94 | Upgrade
|
| Investing Cash Flow | -11.71 | -18.2 | -31.25 | 6.01 | -92.11 | Upgrade
|
| Short-Term Debt Issued | 3 | - | 5.55 | 2.16 | - | Upgrade
|
| Long-Term Debt Issued | 200.19 | 253.03 | 342.11 | 374.88 | 407.19 | Upgrade
|
| Total Debt Issued | 203.19 | 253.03 | 347.66 | 377.05 | 407.19 | Upgrade
|
| Short-Term Debt Repaid | - | -7.71 | - | - | -15 | Upgrade
|
| Long-Term Debt Repaid | -266.38 | -340.29 | -359.87 | -363.89 | -460.68 | Upgrade
|
| Total Debt Repaid | -266.38 | -348 | -359.87 | -363.89 | -475.68 | Upgrade
|
| Net Debt Issued (Repaid) | -63.18 | -94.97 | -12.21 | 13.16 | -68.49 | Upgrade
|
| Issuance of Common Stock | - | - | 0.8 | - | 105.31 | Upgrade
|
| Other Financing Activities | -23.25 | -27.42 | -24.18 | -27.03 | -40.43 | Upgrade
|
| Financing Cash Flow | -86.43 | -122.39 | -35.59 | -13.87 | -3.61 | Upgrade
|
| Foreign Exchange Rate Adjustments | -13.18 | 5.28 | -5.51 | 6.25 | 1.25 | Upgrade
|
| Net Cash Flow | -7.33 | -55.71 | 16.16 | -16.14 | 25.38 | Upgrade
|
| Free Cash Flow | 89.18 | 60.43 | 67.68 | -17.61 | 43.81 | Upgrade
|
| Free Cash Flow Growth | 47.58% | -10.72% | - | - | -32.37% | Upgrade
|
| Free Cash Flow Margin | 23.34% | 14.85% | 15.10% | -2.67% | 7.28% | Upgrade
|
| Free Cash Flow Per Share | 0.23 | 0.15 | 0.17 | -0.04 | 0.12 | Upgrade
|
| Cash Interest Paid | 23.25 | 27.42 | 24.18 | 27.03 | 33.17 | Upgrade
|
| Cash Income Tax Paid | -0.15 | 2.3 | 4.5 | 4.85 | 10.21 | Upgrade
|
| Levered Free Cash Flow | 65.88 | 83.52 | 82.33 | -36.52 | -40.9 | Upgrade
|
| Unlevered Free Cash Flow | 80.7 | 100.65 | 97.44 | -19.63 | -24.13 | Upgrade
|
| Change in Net Working Capital | -52.84 | -100.38 | -112.52 | 76.42 | -20.34 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.